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Changes of serum aldosterone and ANF levels by albumin-lasix therapy
in children with nephrotic crisis. C. W. Ko, J.H. Koo, and W.J. Lee,
Departments of Pediatrics and Physiology, Kyungpook National Uni-
versity, School of Medicine, Taegu, Korea. During nephrotic crisis,
albumin-lasix therapy has been utilized frequently for the control of
oliguria combined with severe edema. The present study was conducted
to see the change of volume status induced by albumin-lasix therapy in
children with nephrotic crisis. Serum ANF and aldosterone were
determined by RIA method before, during and after albumin-lasix
infusion. The patients studied consisted of 9 children with nephrotic
crisis (8 MCNS & 1 MPGN) and the following results were obtained. All
patients showed brisk diuresis after albumin-lasix therapy. After albu-
min infusion, serum ANF rose to 70.17 50.66 pgldl from the
pre-infusion level of 18.48 14.97 pgldl, and this increased level
persisted up to 3 hours after lasix infusion. The serum aldosterone level
after albumin infusion decreased to 44.77 37.45 ng/dl from the
pre-infusion level of 166.85 150.11, and this decreased level also
persisted up to 3 hours after lasix infusion. These changes of serum
ANF and aldosterone showed statistical significance (P < 0.05). In
summary, the present study demonstrates that albumin-lasix therapy is
an effective treatment modality in severe nephrotic crisis without
hazardous changes of volume status in patients.
Role of aldosterone in minimal change nephrotic syndrome in children.
S.W. Kim, M.I. Lee, and D.H. Ahn, Department of Pediatrics,
National Medical Center, Seoul, Korea. We studied 11 cases of
minimal change nephrotic syndrome, randomly selected among 16
cases who were proved by kidney biopsy at the Department of
Pediatrics, National Medical Center during the period from January
1985 through December 1987 to clarify the role of serum aldosterone in
sodium regulation in minimal change nephrotic syndrome. These pa-
tients were studied serially at 3 different stages in their clinical course.
These were the stages of edema formation, diuresis and remission,
respectively. The results were summarized as follows: I) In the
edema-forming stage, all patients showed hypoalbuminemia with 1.42
0.23 gldl of mean serum albumin. Serum albumin was increased to 2.60
0.55 gIdl in the stage of diuresis, and 4.01 0.77 mgldl in the stage of
remission. 2) Urinary protein excretion was 6.52 4.66 g/dl in the stage
of edema, 0.55 0.66 gldl in the stage of diuresis, and urinary protein
excretion was completely diminished in the stage of remission in all the
patients. 3) Urinary sodium excretion was suppressed to 31.2 30.13
mEq while on 2—3 g of a daily allowance of sodium in the edema-forming
stage, and was exaggerated to 95.7 47.39 mEq in the stage of diuresis.
In the stage of remission, sodium was shown to be well balanced
between its intake and output. 4) Glomerular filtration rate (GFR)
expressed by creatinine clearance was 72.7 27.63 ml/min, 87.8
19.51 mI/mm and 82.3 20.29 mI/mm in each stage, respectively. 5)
Plasma aldosterone was elevated to 40.13 36.11 ng/dl in the edema-
forming stage and decreased to 10.05 8.54 ng/dl in the diuretic stage.
In the stage of remission, plasma aldosterone was 16.78 9.08 ng/dl,
showing a significant difference between the edema-forming stage and
diuretic stage. 6) The amount of 24-hour urinary sodium excretion had
an inverse correlation with plasma aldosterone but showed no statistical
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significance between them. 7) The systolic blood pressure was 105.5
36.68mmHg, 119.4 1l.72mmHgand 121.5 14.92mmHgineach
stage, and diastolic blood pressure was 69.1 13.0 mm Hg, 79.1
10.68 mm Hg and 78.5 8.83 mm Hg in each stage, respectively. 8) In
conclusion, the renin-angiotensin aldosterone system was suggested to
play a pathogenic role in edema formation in minimal change nephrotic
syndrome in children.
Blunted release of atrial natriuretic factor in patients with nephrotic
syndrome after supine bicycle exercise. 5K. Park, Y.G. Park, C.S. Lee,
S.K. Kang, S.H. Kim, and K. W. Cho, Department of Internal Medicine
and Physiology, Chonbuk National University Medical School,
Chonju, Korea. The mechanism by which the patients with nephrotic
syndrome (NS) form edema has not been fully elucidated. The exact
role of atrial natnuretic factor (ANF) in the pathogenesis of edema in
NS has not yet been extensively investigated. Recently, diminished
responsiveness of the kidney to the natriuretic action of ANF was
suggested to contribute to edema formation in NS. To investigate the
possible contribution of ANF to edema formation in NS, we subjected
nephrotic patients and healthy volunteers to supine bicycle exercise(SBE), a maneuver that seemed to increase the venous return, and
enhance the release of ANF. Plasma concentrations of immunoreac-
tive-ANF were measured before and after SBE. Results showed that
there was a significant rise of plasma concentration of ANF in 14
healthy controls after SBE (from 37.11 7.06 to 46.67 7.99 pg/mI;
mean SE; P < 0.05). Meanwhile, there was an insignificant fall of
plasma concentration of ANF in 17 patients with NS (from 37.93 6.25
to 30.05 5.25 pg/ml). The change of plasma concentration of ANF in
healthy controls was significantly different from that in patients with MS
(P < 0.05). The mean baseline value of ANF in healthy controls was the
same as that of NS. These data showed that SBE was a simple
maneuver to stimulate the release of ANF in healthy controls. In
contrast, it failed to stimulate the release of ANF in patients with NS.
In summary, our data suggest that there might be a blunted release of
ANF in patients with NS.
Atrial natriuretic peptide attenuates the development of hypertension in
2-kidney, 1-clip Goldblatt rats. K.C. Choi, Y.J. Kang, and J.E. Lee,
Department of Internal Medicine and Physiology, Chonnam University
Medical School, Kwangju, Korea. The effects of atrial natriuretic
peptide (ANP) on the development of hypertension in 2-kidney, 1-clip
rats were examined. In one group of rats, ANP infusion (500 ng/hr, i.v.)
was started immediately after clipping the renal artery. Another group
of rats with one kidney clipped was without ANP infusion and served as
a control. Blood pressure was measured on days 4, 7, and 10 following
clipping of the renal artery. When the last blood pressure measurement
was finished, a blood sample was collected by decapitation to measure
plasma renin activity (PRA), and both kidneys were removed to weigh
and to measure the renin content. The AMP-infused group showed an
attenuation of the increase in blood pressure compared to the non-
infused control group. PRA was lower in the ANP-infused group than in
the non-infused group. Cortical renal renin content (RRC) of the clipped
kidney was not different between the ANP-infused and non-infused
groups, although the clipped kidneys showed a higher RRC and
weighed less than the non-clipped contralateral kidneys within each
group. In contrast, sham-clipped rats did not show significant changes
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in any of the parameters examined regardless of whether ANP was
infused or not. These results demonstrate that chronic ANP infusion
does not prevent but does attenuate the development of hypertension in
2-K, 1-C rats. It is suggested that ANP plays a role in the long-term
regulation of blood pressure, at least in part, by antagonizing the
renin-angiotensin system.
Intracellular free Ca + in essential hypertensive patients. Y.S. Yoon,
IS. Park, S. Y. Kim, W.S. Woo, E.J. Choi, and B.K. Bang, Dept. of
Internal Medicine, Catholic Univ. Medical College, Seoul, Korea.
Recent hypotheses have attempted to relate essential hypertension in
humans to some abnormality in calcium homeostasis, manifested by
both a reduction in plasma-ionized calcium (McCarron, 1982) and an
increase in platelet intracellular free calcium concentration (Ca)1
(Erne et al, 1984). (Ca)1 was studied in platelets of essential hyper-
tensive subjects (N = 25) and normotensive controls (N = 20) under
basal conditions, using the fluorescent calcium indicator Fura 2-AM.
The results were as follows: I) Intraplatelet free calcium levels were
significantly higher in patients with hypertension than in normotensive
subjects (222.4 48.0 vs. 119.6 10.9 nM; P < 0.0001). 2) There was
a close correlation between (Ca)1 and systolic, diastolic and mean
blood pressure (N = 45;r = 0.807 for SBP, 0.728 for DBP and 0.800 for
MBP; P < 0.0001, respectively). 3) Antihypertensive treatment with
calcium-entry blocker or beta-blockers resulted in a reduction in
intracellular free calcium, and this significantly correlated with the fall
in blood pressure (P < 0.0001, respectively). 4) There was a significant
correlation between (Ca) and serum cholesterol concentrations (r =
0.462, P < 0.05). In conclusion, an increased (Ca)1 in hypertensive
subjects suggests a close link between calcium reflux, intracellular
calcium and vascular tone, which may be determined by the unknown
humoral factors that concern the regulation of blood pressure.
A clinical trial of cyclosporin A in childhood nephrotic syndrome. E.K.
Sohn, and B.S. Cho, Department of Pediatrics, College of Medicine,
Kyung Hee University, Seoul, Korea. T cell dysfunction was postulated
in the pathogenesis of idiopathic nephrotic syndrome. Cyclosporin A
has a highly selective immune suppressive action by inhibition of the
production of interleukin-2 by helper T cells. We treated 16 steroid-
resistant or steroid-dependent nephrotic syndrome patients with cyclos-
porin A (5—7 mg/kg/day) for 8 weeks in combination with alternate day
prednisolone therapy. The results were as follows: 1) All patients
responded to cyclosporin A treatment. Response has been maintained
for 2—25 months in 14 patients and relapses occurred in 2 patients after
discontinuation of cyclosporin A on follow-up study. 2) Severe side
effects of long-term PDL therapy, for example, osteoporosis or marked
Cushingoid appearance, were improved by decreased dosage of steroid,
which was possible by cyclosporin A combination therapy. 3) One of
the relapsers showed relatively high pre- and post-therapy interleukin-2
levels and in the other relapser, the post-therapy level of interleukin-2
was not suppressed. 4) The most common side effect of cyclosporin A
was hypertrichosis, which was found in all patients, and infection
(Moniliasis) was observed but nephrotoxicity was not. Thus, long-term
follow-up studies of cyclosporin A therapy in childhood nephrotic
syndrome remain to be evaluated, but short-term follow-up results of
cyclosporin A in the treatment of frequent relapsing or steroid-resistant
nephrotic syndrome were effective without significant side effects.
The therapeutic effects of cyclosporin in nephrotic syndrome. P.K.
Kim, M.S. Park, and J.K. Lee, Department of Pediatrics, Yonsei
University College of Medicine, Seoul, Korea. An enormous number of
reports pertaining to the use f cyclosporin A (CsA) have already been
accumulated since 1977. However, the therapeutic effects of CsA in
nephrotic syndrome have not been clearly understood. In addition,
since CsA is an immunosuppressive agent and is known to have a
number of side effects, it must be fully stressed that these adverse
effects might occur during the treatment. CsA was used in 25 patients
with various types of nephrotic syndrome. There were 16 cases of
minimal change nephrotic syndrome (MCNS), 4 membranous glomer-
ulonephritis (MGN), 3 membranoproliferative glomerulonephritis(MPGN), and 2 focal segmental glomerular sclerosis (FSGS). The
treatment regimen was 100 mg/M2/day at initial administration with
increments of 20—30 mg/day to achieve a blood level of 200—400 ng/ml in
6 months. The number of relapses, renal functions and side effects were
monitored. Among 16 patients with MCNS, 8 cases (50%) had relapses
after CsA treatment. Four out of 10 steroid-responsive patients (40%),
compared to 4 out of 6 steroid-resistant patients (67%), had relapses. In
regard to the mean number of relapses during the 6 month periods
before and after CsA treatment, there was a significant decrease in
MCNS patients. Furthermore, the decrease in number of relapses was
conspicuous in the steroid-responsive group in contrast to the steroid-
resistant group. In most patients, cessation of proteinuria occurred.
And even though not in remission, the total serum protein and albumin
levels normalized after CsA treatment. As previously reported, the side
effects were all transient except in one patient who died of bacterial
meningitis during the CsA treatment, but there was no definite relation
to the use of CsA.
Changes in anionic sites on the glomerular basement membrane and the
role of reactive oxygen species in puromycm aminonucleoside nephrosis.
H.!. Cheong, Y. Choi, K.W. Ko, M.J. Shin, and M.S. Kim, Depart-
ments of Pediatrics and Pharmacology, National University, Seoul,
Korea. An experimental model of puromycin aminonucleoside (PA)
nephrosis (PAN) was developed with the aim of evaluating the role of
reactive oxygen species (ROS) in changes in the anionic sites (AS) on
the glomerular basement membrane (GBM). By administrating the
various ROS inhibitors together with PA, we tried to observe the
accompanying changes in the AS. Albuminuria was quantitated prior to
and 7 days after PA treatment, and blood chemical and renal histolog-
ical examinations were done 7 days after PA also. The AS on GBM
were stained with a cationic marker of polyethyleneimine and we
measured the change of malondialdehyde (MDA) renal tissue level








No. of AS on LRE
(No.!! ,000 nm of
GBM)
PA 10 2.2 0.3 11.4 6.9 2.6 1.0
PA + SOD 9 2.5 0.4 3.2 1.7 11.7 2.8
PA + CAT 5 2.0 0.4 9.2 4.8 1.9 0.6
PA + DMSO 5 2.2 0.2 11.1 4.9 3.6 1.1
PA + Allo 5 2.5 0.5 3.7 2.5 13.7 1.3
Saline 15 2.9 0.2 1.2 0.4 20.0 1.6
(Abbreviations are: SOD, superoxide dismutase; CAT, catalase;
DMSO, dimethyl sulfoxide; Allo, allopurinol; LRE, lamina ram ex-
terna).
The renal tissue level of MDA was significantly higher after (1.97
0.55) PA administration than before (1.16 0.44) as measured by the
absorbance at 533 nm/g protein. These results suggest that ROS
(especially superoxide anion) produced intracellularly by the hypoxan-
thine-xanthine oxidase system play an important role in the develop-
ment of albuminuria in PAN, and there is a loss of AS from GBM and
a resultant charge-selective defect in this animal model of nephrotic
syndrome,
Effect of sodium cromoglycate on the induction of experimental IgA
nephropathy. S. Y. Jin and I.J. Choi, Department of Pathology, Yonsei
University College of Medicine and Wonju College of Medicine, Wonju,
Korea. Healthy female ddy mice were selected and divided randomly
into six groups. Live or inactivated poliomyelitis vaccine (polio) was
administered orally or intramuscularly to produce experimental IgA
nephropathy. On the assumption that this disease was induced by
mucosal immunization, sodium cromoglycate (SCG) was given together
with polio to identify its influence on the induction of IgA nephropathy.
Mucosal and systemic immunity could be induced by the administration
of polio. The laboratory morphological findings included proteinuria,
increased serum IgA levels, mesangial cell proliferation, mesangial
matrix widening, mesangial deposits of IgA, and large electron-dense
deposits in the mesangium. Concurrent administration of SCG and polio
resulted in a significant decrease in serum IgA levels and mesangial IgA
deposits. The addition or abstinence of SCG after the 70th day did not
influence the glomerular mesangial IgA deposition. But the serum IgA
level was still decreased by the continuous treatment of SCG even after
the 70th day. Mesangial IgA nephropathy simulating IgA nephropathy
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in humans was induced in ddY mice using polio. Its induction could
largely be prevented by the concurrent use of SCG. But mesangial IgA
deposits already present were not cleared by the late administration of
SCG.
Clinicopathological study of HB5Ag associated membranous glomeru-
lonephropathy. J.K. Rhim, P.K. Kim, J.S. Lee, H.J. Jeong, and I.J.
Choi, Departments of Pediatrics and Pathology, Yonsei University
College of Medicine, Seoul, Korea. We described 22 patients with HBs
associated membranous glomerulonephropathy. The children were
predominantly boys (19 of 22) and their mean age was 8.8 years. Most
of the patients had nephrotic syndrome but some presented gross
hematuria. BUN and creatinine were within normal range. Although
clinical evidence of liver disease was not present, ten of 22 patients had
elevated liver enzymes. Liver biopsies performed in three children
revealed chronic persistent hepatitis in one, the healing stage of acute
hepatitis in another and normal findings in the third. A low serum C3
value was observed in one patient. Renal biopsy specimens revealed
stage I in two patients, stage II in 19 and stage III in one. Glomerular
filtration rates were all within normal range regardless of stages. Six
biopsy specimens were positive for tissue HBs antigen and these were
classified as group I. The other tissue HBs antigen negative specimens
were classified into group II. The average for 24 hr urine protein was 7.7
g for group I which was significantly different from 2.01 g obtained from
group II. The average serum IgG level was 446.2 mgldl for group I and
466.6 mg/dl for group II, which was decreased compared to the
age-matched standards. The average serum 1gM was 131.5 mg/dl for
group I and 224.5 mg/dl for group II with significant difference between
the groups but all of which were within the normal range.
Clinical significance of tubular proteinuria in acute oliguric renal
failure. S.H. Yu, S.S. Kim, E.T. Kang, Y.J. Cha, Departments of
Internal Medicine and Clinical Pathology, Chung Ang University
Hospital, Seoul, Korea. Although proteinuria is one of the urinary
findings in acute renal failure, the measurement of protein by paper strip
method can detect albumin only. Because the pathology of acute renal
failure is acute tubular necrosis, tubular proteinuria could be one of the
pathognomonic findings. However, there have been few studies con-
cerning tubular proteinuria in acute renal failure. Recently SDS-PAGE,
which can differentiate proteinuria according to molecular size, was
introduced in clinical use. We studied the proteinuria in 25 patients with
acute oliguric renal failure using micro slab gel SDS-PAGE. The results
were as follows: 1) The study group comprised 14 males and 11 females.
The mean age was 49 years (range: 17—78 years). 2) There were 12 cases
of medical acute renal failure, 11 cases of surgical acute renal failure
and 2 cases of obstetric acute renal failure. 3) In the early stage of 6
cases, no tubular proteinuria could be detected. 4) In the oliguric stage
of all 15 cases, complete tubular proteinuria was detected. Among
them, unselective glomerular proteinuria was associated in 8 cases and
selective glomerular proteinuria in 7 cases. 5) In the diuretic stage of all
8 cases, partial tubular proteinuria was detected. Among them, 2 cases
were associated with unselective glomerular proteinuria and 6 cases
with selective glomerular proteinuria. 6) In the convalescent stage of 2
cases, tubular proteinuria disappeared, but mild proteinuria persisted.
The above results suggested that the measurement of tubular protein-
uria using micro slab gel SDS-PAGE in acute renal failure showed a
close relation to the clinical stage.
Changes of urine electrolytes and urine anion gap in hemorrhagic fever
with renal syndrome (Korean hemorrhagic fever). G.H. Kim, W.S.
Yang, J.S. Han, S. Kim, and J.S. Lee, Dept. of mt. Med., Seoul
National University Hospital, Seoul, Korea. Recently, the urine anion
gap (urine A G) has been introduced as an index of distal tubular
acidification. In Korean hemorrhagic fever (KHF), tubular dysfunction
is expected from the characteristic clinical findings, such as delayed
recovery of urinary concentrating power. To observe the relationship of
urine A G with tubular dysfunction and clinical severity in patients with
KHF, serial measurements of spot urine electrolytes and osmolality
were performed in 16 patients serologically confirmed as KHF with
typical clinical manifestations. From the spot urine electrolyte concen-
trations, urine anion gaps were calculated and compared with variable
clinical indices. Spot urine electrolyte concentrations showed serial
changes from the oliguric to convalescent phase. Spot urine Na and K
concentrations were higher in the early stage (oliguric and early diuretic
phases) than in the late, but spot urine Cl concentration had no
differences during all phases. Urine A G was 55.9 9.9 (mean SD),
348 14.1, 143 7.6 and 14.6 4.7 mEq/liter in the oliguric, early
diuretic, late diuretic and convalescent phase, respectively. Therefore,
it decreased serially from the oliguric phase. Urine osmolality was 283.7
18.9, 273.3 99.2, 168.8 58.8 and 151.5 67.2 mOsm/kg in the
oliguric, early diuretic, late diuretic and convalescent phase, respec-
tively. Therefore, it decreased serially from the oliguric phase. The
initial spot urine A G of each patient was related with the clinical
severity in the early stage of KHF that is classified by the degree of
fever, gastrointestinal symptoms, hemorrhagic manifestations, and
proteinuria. From the above results, we concluded that the changes of
urine A G from the oliguric phase to the convalescent phase were
related with the renal tubular dysfunction in KHF and with the clinical
severity as well.
Ibiopathic hypercalciuria in children. Y.H. Ahn, K.H. Kim, C.W. Ko,
and J.H. Koo, Department of Pediatrics, Kyungpook University,
School of Medicine, Taegu, Korea. A prospective study was conducted
to determine the frequency and clinical characteristics of childhood
idiopathic hypercalciuria, especially in children with primary hema-
tuna. The baseline study group consisted of 83 children with minor
illnesses who were admitted to the pediatric department from July to
September 1988. The hematuric study group consisted of 25 children
with recurrent gross or persistent microscopic hematuria of unknown
etiology for the duration of 1 year from July 1987 to July 1988. The
following results were obtained. From 83 cases in the baseline study
group, 5 cases (6.6%) were found to have idiopathic hypercalciuria,
showing urinary calcium excretion over 4 mg/kg/day. Out of 25 cases in
the hematuric group, 6 cases (24%) were diagnosed as idiopathic
hypercalciuria and the oral calcium loading test showed absorptive type
in 4 and renal type in 2. One child showed renal stone. Oral hydrochlo-
rothiazide administration resulted in prompt cessation of hematuria in 3
cases (I absorptive and 2 renal cases). In summary, the present study
demonstrates that idiopathic hypercalciuria is a major cause of primary
hematuria in children and in these children, close follow-up should be
done, especially in regard to renal stone formation.
Measurement of the mean cellular volume of urinary red blood cells for
determination of glomerular bleeding in children with hematuria. W. Y.
Chung, S.H. Lee, C.H. Kim, and S. Y. Lee, Dept. of Pediatrics, College
of Medicine, Inje University, Pusan Paik Hospital, Pusan, Korea.
Morphologic analysis of urinary red blood cells (URBC) is of value for
determination of the origin of hematuria in children, since the glomer-
ular hematuria has a dysmorphic pattern, while the nonglomerular
hematuria has an isomorphic pattern. We measured the mean cellular
volume (MCV) of URBC by a Coulter counter, model S Plus, i.v. in 37
children with hematuria. The patients were divided into 2 groups as
having glomerular disease and nonglomerular disease. The patients with
glomerular disease had a significantly lower MCV than those with
nonglomerular disease (69.77 8.47 fi vs. 87.45 4.39 fi: P < 0.001 by
Student's t-test). All patients with nonglomerular disease had MCV
values more than 80 fi. The results were consistent with other reports in
which URBC of glomerular disease had a smaller volume than those of
nonglomerular origin. We concluded that MCV measurement of URBC
will be helpful for determination of the origin of hematuria in children,
since it is quite a simple, inexpensive and effective method as a routine
screening procedure to avoid unnecessarily invasive examinations.
Kidney biopsy findings and renal symptoms of chronic carbon disulfide
intoxication. J.R. Koo, H.M. Kwon, B.S. Kim, Y.J. Kwon, W. Y. Cho,
H.K. Kim, and N.H. Won. Departments of Internal Medicine and
Pathology, College of Medicine, Korea University, Seoul, Korea.
Carbon disulfide (CS2), a volatile gas used in the synthesis of viscose
rayon, is a neurotoxin and has an atherogenic effect on the vascular
system. The vascular effect was regarded as a cause of renal impair-
ment. We report the renal symptoms of chronic CS2 intoxication based
on renal biopsy specimens. 1) A total of 16 subjects, 10 males and 6
females, with a history of working at a rayon factory were examined.
The mean age was 46 yrs (38—51 yrs) and the exposure duration was 12.6
yrs (6—18 yrs). 2) Of the total 16 cases, 9 patients had a history of
hypertension with proteinuria of 1.7 g to 2.9 g/day and one patient had
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an impaired glucose tolerance test. 3) Among the patients with
azotemia, two had diffuse and nodular intercapillary glomemlar sclero-
sis, hyaline arteriosclerosis, tubular atrophy and tubulointerstitial ne-
phritis under light microscopy. In the same patients, focal deposits of
1gM, C3 and C4 on glomeruli and vessel walls were noted on immuno-
fluorescence microscopy. Intercapillary glomerulosclerosis with severe
tubulointerstitial nephritis was also noted in one patient without
azotemia and hypertension. In 7 cases, the basement membranes were
significantly thicker, with a mean of 764 nm (520—1190 nm), than the
normal thickness (328.8 nm) under electron microscopy (P < 0.01).
Glomerular disease and urinary tract tuberculosis (UT Tbc). D.G.
Shin, B.A. Yu, and D.K. Cho, Department of Internal Medicine,
Kyungpook, University Hospital, Taegu, Korea. The most common
symptoms associated with UT Tbc are those related to bladder involve-
ment and cystitis such as frequency, nocturia and dysuria. But it is
possible to find a coexisting UT Tbc in patients whose symptoms are
not typical. We here report 7 cases (3 men and 4 women) of UT Tbc
whose symptoms were mostly of glomerular lesions. Impressions on
admission were nephrotic syndrome in 2 cases, renal tuberculosis in 2,
RPGN in I, CGN in 1 and proteinuria in 1. Direct smears for AFB in
urine were positive in 4 cases and mycobacteria was cultured in 1.
Urinary pH was distributed between 5.0 and 6.0 in all cases. Proteinuria
more than 3.5 g a day was noted in 6 cases. All patients showed pyuria
and microscopic hematuria. Radiologic examination revealed con-
tracted urinary bladder in 1. Renal biopsy was performed in 5 cases.
Biopsy findings were crescentic GN in 2 cases, FSGS in 1, MPGN in 1,
and none were made in 1. In conclusion, even in patients with
glomerular symptoms, UT Tbc should be sought in the areas where
pulmonary Tbc is still an important hazard.
Clinical study on 70 cases of renal tuberculosis at Kyung Hee University
Medical Center. S.P. Hong, Y.S. Hwang, T.W. Lee, and M.J. Kim,
Department of internal Medicine, Kyung Hee University Medical
Center, Seoul, Korea. Clinical observation was made on 70 cases of
renal tuberculosis in Kyung Hee University Medical Center from
January 1980 to December 1988. The results were summarized as
follows: 1) The male to female ratio was 1.1: 1. The patient's age ranged
from 11 to 68 years and the peak incidence was in the 3rd (29%) and 4th
(27%) decade. 2) The major presenting manifestations were nonspecific
ones such as vague flank pain (41%), hematuria (39%), urinary fre-
quency (24%), painful urination (19%) and so on. 3) Urinary findings
revealed pyuria (79%), proteinuria (56%), and hematuria (54%). 4)
Direct smear for AFB in morning concentrated urine was positive in 17
cases (26%) and a smear negative but culture positive result was noted
in 8 cases (12%). 5) The intravenous pyelographic findings in 57% of
cases of renal tuberculosis were nonvisualization (54%), calyceal de-
struction (46%), ureteral stricture (12%), delayed visualization (11%),
hydronephrosis (5%), and cavity formation (4%). Nine cases (16%)
were affected in both sides, 22 cases (39%) in the right and 24 cases
(42%) in the left side. 6) Past or present extrarenal tuberculosis was
noted in 34 cases (49%), and 22 cases (64%) of pulmonary tuberculosis
and 8 cases (24%) of bone tuberculosis were noted. 7) Patients were
treated by chemotherapy (53%), chemotherapy with nephrectomy
(33%), and chemotherapy with reconstructive surgery (11%).
A clinical observation of renal tuberculosis in 1054 cases throughout
thirty years. J.Z. Lee and J.B. Yoon, Department of Urology, College
of Medicine, Pusan National University, Pusan, Korea. To survey the
clinico-pathological trends of genitourinary tuberculosis of the past
thirty years, we observed 1054 patients with genitourinary tuberculosis
who were managed at the Department of Urology, Pusan National
University Hospital from 1958 to 1987 (the early period: 1958—1967, the
middle period: 1968—1977 and the late period: 1978—1987). The results
were as follows. 1) The distribution of patients in each period was 342
in the early period, 361 in the middle period and 351 in the late period
and a natural decline in the number of patients between each period was
not seen. However, the incidence of genitourinary tuberculosis treated
at the outpatient department in each period was shown to be declining,
with 4.2% in the early period, 2.8% in the middle period, and 1.6% in
the late period. Also, the distribution in the patient age group was
mainly in the third and fourth decades in the early and middle period,
whereas, in the late neriod, a relatively even distribution among the
third, fourth and fifth decades of life was noted. 2) Initial complaints
were irritable bladder symptoms, renal and systemic symptoms in order
of frequency. The incidence of turbid urine was markedly decreased but
silent hematuria was slightly increased in the late period. 3) The
detection rate of acid fast bacilli (AFB) by stained smear in the
untreated group was 26.5% in the initial period, 54.4% in the middle
period, and 58.1% in the late period. 4) On cystoscopy, progressive
increases in the incidence of nonspecific inflammatory lesions were
noted in the middle and late period compared to the initial period that
were 37.6, 45.9 and 21.2%, respectively. 5) Uroradiologically, advanced
excretory urographic findings including nonvisualized kidney were
decreased insidiously. 6) Renal pelvis urine was more dominant for the
detection of AFB and proteinuria than bladder urine and also showed
lower specific gravity. 7) The interrelationship between the histopath-
ological features of surgically resected kidney and the length of sys-
temic chemotherapy showed that most tuberculomas disappeared after
12 months of LNH, PAS and SM (KM) regimen, and also disappeared
after 6 months of INH, EMB and RIF (PZA) regimen.
A retrospective clinical study of 65 cases with renal tuberculosis. S.S.
Kim, S.H. Yu, and E.T. Kang, Department of Internal Medicine,
Chung Ang University Hospital, Seoul, Korea. With the improvement
of chemotherapy against tuberculosis, the rate of prevalence of tuber-
culosis in Korea has been decreased from 5.1% in 1965 to 2.0% in 1985.
However, there were few studies concerning renal tuberculosis. We
performed a clinical study of about 65 patients with renal tuberculosis
who had visited the Departments of Internal Medicine and Urology of
Chung Ang University Hospital between 1984 and 1988. The results
were as follows: 1) The ratio of males to females was 1.8: 1. 2) The mean
age was 42.5 years (range: 15—76 years). 3) Renal tuberculosis was
associated with ureteral tuberculosis in 41%, tuberculous cystitis in
39% and tuberculous epididymitis in 17%. 4) Active pulmonary tuber-
culosis and old pulmonary tuberculous lesions were found in 11% and
38%, respectively. 5) Bone, intestine, and larynx were associated with
renal tuberculosis in 1 case each. 6) The chief complaints were urinary
symptoms in 57% (frequency in 27%, flank paln in 22%, hematuria in
21%, dysuria in 21%), systemic symptoms in 36% and scrotal mass in
5%. 7) Hematologic findings revealed that anemia was present in 20%.
On urinalysis, pyuria (WBC > 6/hpf), hematuria (RBC > 6/hpf) and
proteinuria was observed in 71%, 68% and 66%, respectively, but there
was no urinary abnormality in 9 cases. Decreased renal function (serum
Cr > 1.2 mg/dl) was noticed in 38%. 8) In a microbiologic study
including direct smear and urine culture, urine AFB was positive. 9)
Radiologic studies including KUB, IVP, voiding cystourethrography,
AGP, ultrasonography and CT were done. Abnormalities of IVP were
observed in 45%, but no abnormalities were found in 5% by any studies.
10) Renal tuberculosis was confirmed in 25% by histologic examination
of bladder biopsy or nephrectomized specimens, and in 7% by taking
past history. 11) Renal tuberculosis was treated by surgery (nephrec-
tomy, nephrostomy, ureterostomy, etc.) with antituberculous chemo-
therapy in 17%; the others were treated with chemotherapy alone. 12)
As the result of treatment, 57% of patients were cured and 5% of
patients progressed to end-stage renal failure.
Clinical features of renal tuberculosis in 70 cases. Y. Lee, H. Oh, J.
Park, S. Kim, W. Jang, and G. Yang, Hallym University College of
Medicine, Chuncheon, Korea. Tuberculosis is one of the major infec-
tious diseases in Korea, although its prevalence has been falling. In
renal tuberculosis, there are considerable complications at the time of
diagnosis because of the long duration from exposure to onset of
symptoms, which are usually nonspecific. In spite of antituberculous
chemotherapy, complications may progress and cause obstructive
uropathy. Between January 1984 and December 1988, 70 patients were
discharged with renal tuberculosis at the Hallym University Hospital.
The diagnosis was established on positive urine acidfast bacilli (AFB)
staining, positive urine AFB culture, histopathology, and urographic
features. Renal tuberculosis was predominant in the 4th and 5th
decades, the average age was 39.8 years and males predominated by
1:8: 1. The most common presenting symptom was gross hematuria
(45.7%), then flank pain, dysuria, nocturia and frequency, and fever as
a constitutional symptom in that order. An abnormal urinalysis finding
was observed in 82.9% of cases and azotemia was found in 25.7%.
Asymptomatic urinary abnormality was noted in 25.7%. Urine AFB
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staining was positive in 27.1%, positive urine AFB culture was found in
5.7%, and 34.3% of cases showed characteristic histopathologic finding.
Abnormal urographic findings were seen in 98.5%, and the left kidney
was affected predominantly (41.5%). An abnormal chest X-ray finding
was observed in 64.3%, and previous extrarenal tuberculosis was noted
in 24.3% with an average duration of 9.3 years. Active extrarenal
tuberculosis was associated in 14.3% of cases. The most common
complication was hydronephrosis and hydroureter (44.3%), followed by
stone and secondary infection in that order. Among 6 azotemic patients
who were followed more than 3 months after treatment, the serum
creatinine level was decreased in 5 patients.
Surgical treatment of genitourinary tuberculosis using Mainz pouch.
CS. Yoon, K.B. Kim, and H. 1'. Rhew, Department of Urology, Kosin
Medical College, Pusan 602 -030, Korea. Contracture of the bladder due
to genitourinary tuberculosis results in diminished vesical capacity,
frequency, urgency, vesicoureteral refiux (VUR) and ureteral obstruc-
tion and it demands correction as it can lead to renal deterioration. In
1988, Mikuliz reported bladder augmentation by use of an ileal loop,
and then various procedures were reported but they had some prob-
lems. So we have used the Mainz pouch which was introduced by
Thuroff et al in 1985. Case I. A 39-year-old female patient presented
with a 2-month history of intermittent gross hematuria and left flank
pain. She had undergone a right nephrectomy 10 years ago because of
renal tuberculosis. The serum BUN/Cr ratio was 25/2.2. Excretory
urography (IVP) showed severe hydronephrosis and voiding cystoure-
thrography (VCUG) showed VUR Grade V, left and bladder capacity
was less than 100 ml. Postroperative VCUG showed no VUR and
bladder capacity increased to 230 ml. The voiding interval was 4—6
hours. The BUN/Cr ratio increased to 90/6.4 temporarily but returned
to 1/1.3 at postoperative 10 days. Case 2. A 42-year-old female patient
presented with a 4-month history of severe dysuria and frequency. The
urine color was turbid, bladder capacity was less than 50 ml and the
voiding interval was 30 minutes. The serum BUN/Cr ratio was 17/1.2.
IVP showed severe hydronephrosis, right and VCUG showed both
VUR (Rt. Grade IV, Lt. Grade II). Postoperative VCUG showed no
reflux and bladder capacity increased to 430 ml. The voiding interval
was 6 hours and symptoms disappeared. The serum BUN/Cr ratio was
15/0.9. We obtained good results from the Mainz pouch which had 3
functional features: creation of a low pressure reservoir of adequate
capacity, antirefluxing ureteral implantation achieved by a standard
submucosal tunnel, and continence, depending on the competence of
the bladder neck and urethral sphincter.
Clinical analysis of tuberculosis of the kidney and urinary tract. K.H.
Han, S.K. Park, S.K. Kang, M.C. Kim, andJ.H. Song, Dept. of mt.
Medicine, Chonbuk Nat'!. Univ. Med. Sch., Chonju Presbyterian Med.
Ctr and Won-Kwang Univ. Med. Ctr, Chonbuk, Korea. Tuberculosis
involves not only the lung but also other organs of the body, especially
the kidney and urinary tract. Clinical analysis was made by the authors
on 26 cases of kidney and urinary tract Tbc who were admitted to the
Dept. of mt. Med of the above 3 hospitals during the period from Jan.
1985 to April 1989, and the following results were obtained. The most
common age group was the 20s and 30s (57.8%) and the male to female
ratio was 1:1.7, The lesion site involved right 38.5%, left 42.3% and
both sides 19.2%. The most common symptoms were frequency
(46.2%), flank pain (46.5%), gross hematuria 26.9%), and dysuria
19.2%. Symptom duration prior to admission was 0—6 ms, 46.2%; 2—5
yrs, 23.1%; and over 5 years, 23.1%. The most commonly involved
organ combined with the kidney and urinary tract Tbc was the lung
(50.0%). Urinalysis revealed hematuria in 73.1%, pyuria in 73.1%, and
AFB stain positive in 50.0%. Non- or delayed visualization of the
kidney in IVP was observed in 30.7%, pelvocaliceal dilatation of
destruction in 26.9%, irregularity of ureter dilatation in 26.9%, and
hydronephrosis in 23.1%. Since the kidney is frequently involved in
pulmonary Tbc, lung Thc should be treated intensively.
Clinical characteristics of renal tuberculosis patients presenting with
renal failure. S.W. Kang, H.L. Lee, H.W. Lee, S.f. Lee, K.H. Choi,
H. V. Lee, and D.S. Han, Department of Internal Medicine, Yonsei
University College of Medicine, Seoul, Korea. We reviewed clinical
features, laboratory findings, and the management of 23 patients having
greater than 2.0 mg/dl of serum creatinine concentration on admission
out of 186 patients diagnosed to have renal tuberculosis at Yonsei
Medical Center from Jan. 1979 to Dec. 1988. The mean age was 38.8
13.9 years (mean SD) and the male to female ratio was 1:3: 1. The
most common clinical manifestation was constitutional symptoms, such
as fever, night sweat or weight loss (73.9%). The incidence of urinary
symptoms such as dysuria with frequency, flank pain, and gross
hematuria was 69.6%, 60.9%, and 43.5%, respectively. Hematuria,
pyuria, and proteinuria were documented in the order of frequency. The
positive rate for AFB in urine culture was 30.4%. Abnormal findings in
intravenous pyelography were noted in 94.7%, with hydronephrosis
(84.2%) being the most common finding. On chest X-ray, 7 patients
(30.4%) revealed features compatible to active pulmonary tuberculosis.
All patients except one were treated with antituberculous medications,
and in combination with medication, operative procedures such as
nephrostomy were performed in 12 patients (52.2%). Among 10 patients
who had been followed for more than 6 months following diagnosis, 6
patients showed an improvement in renal function reflected by declining
serum creatinine levels. From these results, it is concluded that despite
the declining incidence, renal tuberculosis should still be considered in
evaluating the patients presenting with chronic renal failure of uncertain
etiology.
Clinical characteristics of tuberculosis in chronic renal failure. H.J.
Yoon, E.T. Kang, J.S. Han, S. Kim, and J.S. Lee, Dept. of Internal
Medicine, Seoul National University Hospital, Seoul, Korea. Tubercu-
losis (Tbc) in chronic renal failure (CRF) has a high prevalence rate but
it is difficult to diagnose because of its vague clinical presentations. We
evaluated the clinical features and diagnostic modalities including
bacteriologic and pathologic findings in 26 patients with Tbc among
1,198 inpatients with CRF from Jan. 1984 to Dec. 1988 and 36 patients
on maintenance hemodialysis during the same period. The prevalence
rate of Tbc was 2.0% (24/1198) of inpatients and 5.6% (2/36) of patients
on maintenance hemodialysis. The mean age was 46/2 years (SD 13.1
year) and eighteen patients were male. Extrapulmonary Tbc (EP) was
present in 50% (13/26). The initial clinical features of pulmonary Tbc
(13/26) were fever, hemoptysis, and weight loss. And in five patients,
there was no symptom suggestive of Tbc. The diagnostic modalities
were sputum smear for tubercle bacilli (AFB) in five and pleural needle
biopsy in two patients. And the others were diagnosed with chest
radiographic findings. The involved sites of EP-Tbc were lymph node,
peritoneum, urinary tract, bone and joint, liver, and soft tissue. Initial
clinical features of EP-Tbc were fever, abdominal distention, persistent
pyuria, dysuria, back pain, and arthralgia. The diagnosis was confirmed
by pathologic findings, isolation of AFB or therapeutic trial. In patho-
logic findings, granuloma with caseation necrosis was observed in two,
and granuloma without caseation necrosis in nine. The mortality rate
was 7.7% (2/26). From the above, the high prevalence of EP-Tbc, vague
clinical presentation and atypical granuloma were the characteristic
features of Tbc in CRF.
Clinical application of short term chemotherapy in genitourinary
tuberculosis. J. W. Sohn and S.G. Chang, Department of Urology,
Kyung Hee University, Seoul, Korea. Since 1984, a 9 month regimen of
chemotherapy has been adopted for the treatment of 39 patients (23 men
and 16 women) suffering from genitounnary tuberculosis. The age range
of patients was from 16 years to 68 years with an average of 35.5 years.
Uring D/S and culture for AFB were positive in 22 patients (56.4%) and
the other patients were diagnosed by radiologic, cystoscopic and
histopathologic examinations. In all patients who had positive urine D/S
and culture for AFB, the urine was sterilized within 3 months after
treatment. Surgical management with chemotherapy was performed in
16 patients. Toxic hepatitis due to developed in 1 patient. The cost of
chemotherapeutics spent in long-term chemotherapy was 3 to 4 times
higher than in short-term chemotherapy. There was no relapse bacte-
riologically during the follow-up periods.
Effect of hepatitis B vaccination in ESRD patients. J.J. Kim, V. V.
Kim, J.S. Lim, T.W. Jang, W.S. Joo, H.K. Kim, and SR. Lee,
Department of Internal Medicine, Kosin Medical College, Pusan,
Korea. HB vaccination of isolated anti-HBc positive patients was
known to be useful to differentiate between chronic infection and
booster protective immunity. The immune response to HB vaccination
in ESRD patients has been poor and better results of immune response
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were reported by reinforced vaccination. We measured anti-HBs sero-
conversion rates in a total of 100 ESRD patients (HD 60, CAPD 37, and
transplantation 3 patients) who were vaccinated with Hepavax®, and
the results were as follows: the anti-HBs seroconversion rate in 54
anti-HBc positive patients was 44.6%, and the anti-HBs seroconversion
rate in 46 anti-HBc negative patients was 34.8%. Anti-HBs seroconver-
sion rates were 38.3% in the HD group, 43.2% in the CAPD group, and
33.3% in the transplantation group. Anti-HBs seroconversion rates in
various dosage groups were 11 out of 46 patients (39.1%) in the 2 vials,
3 times vaccination group, 10 out of 22 (45.5%) in the I vial, 3 times
vaccination group, and 11 out of 28 (39.3%) in the 2 vials, I or 2 times
vaccination group. The seroconverted patients in the 2 vials, 3 times
vaccination group revealed a higher titer and longer sustained anti-HBs
in serum. The anti-HBs seroconversion rate was significantly low in the
group with a longer period of dialysis; 44.4% in the group with less than
a 1 month period of dialysis and 9.1% in the group who had dialysis for
13 up to 36 months (P < 0.05). A high serum level of anti-HBs and its
duration were noted in the 2 vials, 3 times vaccination group. Although
the level of anti-HBs was higher and the duration of the high level was
longer in the 2 vials, 3 times vaccination group, anti-HBs seroconver-
sion rates were the same in the 3 groups with various dosages.
Bone mineral content (BMC) in patients with chronic renal failure
(CRF). S.H. Lee, H.Y. Chung, T.W. Lee, C.G. Lim, and M.J. Kim,
Department of Internal Medicine, Kyung Hee University Medical
Center, Seoul, Korea. Dual energy X-ray absorptiometry (DPX) is one
of the best quantitative methods for the measurement of the BMC in
various metabolic diseases. To evaluate the level of the BMC in CRF,
the effect of treatment modality on BMC, and the factors influencing the
BMC, BMC of the lumbar vertebra (L2-L4) was measured by DPX in 60
patients with CRF and 24 normal controls matched for age and sex. The
results were as follows: 1) The BMC of patients with CRF (0.99 0.17
g/cm2) was significantly lower that that of controls (1.12 0.17 glcm2;
P < 0.025). 2) In females, an inverse correlation was observed between
the age and the BMC (r = 0.42, P < 0.05) with a marked decrease of the
BMC in postmenopausal women. 3) The BMC was low in predialysis
patients with higher levels of serum creatinine ( 10 mgldl) compared to
those with lower levels of serum creatinine (<10 mg/dl; 0.944 1.4 vs.
1.06 0.2 g/cm2; P < 0.05). 4) A difference of BMC was not observed
between predialysis and dialysis patients (1.00 0.19 vs. 1.018 0.18
g/cm2) and a significant correlation was not observed between the BMC
and the duration of dialysis. 5) There was a significant correlation
between the level of serum phosphorus and the BMC in predialysis
patients (r = 0.59, P < 0.001). 6) No significant difference was observed
between hemodialysis and CAPD patients in the level of the BMC (1.05
0.19 vs. 0.96 0.16 glcm2). In conclusion, renal function, sex, age (in
females), and the level of phosphorus (in predialysis) may affect the
level of the BMC in patients with CRF.
Intraplatelet free calcium concentrations in patients with chronic
uremia. Y.S. Yoon, W.S. Koo, E.J. Choi, and B.K. Bang, Division of
Nephrology, Department of Internal Medicine, Catholic University
Medical College, Seoul, Korea. To study the variation and clinical
significance of the intracellular free Ca concentrations, (Ca),
during hemodialysis of human subjects with dialyzed chronic uremia,
the authors measured the (Ca) in the platelets by the intracellularly
trapped fluorescent indicator Fura 2-AM from 20 normal subjects and
42 chronic uremic patients receiving maintenance hemodialysis. The
results were as follows: I) The (Ca) in the pre-dialytic group was
significantly lower than that in normal subjects (102.5 24.4 vs. 119.6
10.9 nM; P = 0.0003). 2) The (Ca)1 in the intra-dialytic group was
markedly higher than that in the pre-dialytic group (159.1 32.4 vs.
102.5 24.4 nM; P = 0.0001). 3) The (Ca) in the post-dialytic group
markedly decreased from the value of the intra-dialytic group to the
level of normal subjects (111.3 25.2 vs. 119.6 10.9 nM; P = NS)
which, however, was higher than that of the pre-dialytic group (P =
0.05), 4) There was a significant correlation between (Ca)1 (differ-
ence from the (Ca of the pre-dialytic group to the (Ca of the
intra-dialytic group) and ApH (difference from the pH of the pre-dialytic
group to the pH of the intra-dialytic group; r = 0.425; P = 0.02). In
conclusion, hemodialysis may acutely affect (Ca)1, possibly through
the acute elevation of extracellular pH, which may lead to an increase
in the rate of calcium influx during hemodialysis.
Change of serum polyamine levels during hemodialysis. W. Y. Cho,
KS. Wee, H.K. Kim, D.J. Won, and BK. Jeon, Departments of
Internal Medicine and Pharmacology, College of Medicine, Korea
University, Seoul Adventist Hospital, Seoul, Korea. We measured
serum levels of polyamine before and during hemodialysis in 3 patients






0 4.80 267b 0.86 0.84 0.91 0.59
30 4.22 1.22 1.22 1.42 1.21 1.31
60 3.78 0.20 1.10 0.68 1.43 0.98
120 6.36 3.33 0.16 0.14 0.08 0.11
240 5.13 1.64 0.28 0.08 0.56 0.47
a time after initiation of hemodialysis
b Data are presented as means SD
Our results suggest that the levels of polyamine are not changed during
hemodialysis and polyamines are not dialyzable. To evaluate the
meaning of these results, further study may be required.
Changes of intraocular pressure during hemodialysis. Y.S. Yoon, W.S.
Koo, Y.S. Yang, K.H. Lee, E.J. Choi, BK. Bang, J.Y. Lee, andH.Y.
Yang, Department of Internal Medicine, Catholic University Medical
College, Department of Opthalmology, Department of Internal Medi-
cine, Daerim St. Mary's Hospital, Seoul, Korea. To evaluate the
changes in intraocular pressure (lOP) during hemodialysis and to
determine whether a correlation exists between changes in plasma
osmolality and lOP, we measured lOP with a Goldmann applanation
tonometer in 18 uremic subjects on the hemodialysis off day and in 35
dialyzed uremic subjects before and within 30 minutes after hemodial-
ysis. I) The mean LOP of 53 uremic subjects was not significantly
different than that of normal subjects (14.4 2.lvs. 13.7 3.6 mm Hg;
P = NS). 2) The lOP of 35 pre-dialytic subjects was 14.1 2.4 mm Hg
in the right eye and 14.5 2.6 in the left eye. The lOP of the
post-dialytic subjects was 16.1 3.2mm Hg in the right eye and 15.6
2.7 mm Hg in the left eye. The mean lOP of both eyes in the
post-dialytic subjects increased significantly compared to that of pre-
dialytic subjects (15.8 2.8 vs. 14.3 2.4 mm Hg; P = 0.02). 3) An
increase in mean lOP of 3 mm Hg or more than the value of pre-dialysis
was observed in 11 subjects (3 1.4%). 4) There was a significant inverse
correlation between the changes of mean lOP and plasma osmolality
during hemodialysis (r = —0.415, P = 0.02). Based on the above
findings, it is suggested that hemodialysis may increase lop possibly
through the disequilibrium of osmolality between the plasma and
intraocular chamber in twice-weekly-dialyzed uremic patients.
Nutritional status in patients with maintenance hemodialysis (HD) and
continuous ambulatory peritoneal dialysis (CAPD). D.S. Han, Y.K. Kim,
K.H. Choi, S.K. Ha, and H. Y. Lee, Department of Internal Medicine,
Yonsei University College of Medicine, Seoul, Korea. Patients under-
going maintenance dialysis therapy have been reported to be wasted or
malnourished in general. To evaluate the nutritional status of patients
undergoing HD and CAPD in Korea, we measured several anthropo-
metric parameters, serum levels of vitamins and amino acids, and daily
nutrients intake by dietary survey. Subjects consisted of 68 cases on
HD, 26 cases on CAPD and 50 controls. Though the mean body weight
of patients was 102.1 12.4% (Mean SD) of ideal body weight, 22.7%
of patients were underweight, below 80% of ideal body weight. Percent
body fat contents of male patients on HD and CAPD (mean SD 19.3
4.3%, 19.0 5.6%) were not different from controls (19.2 3.5%),
but female patients on CAPD (31.2 6.5%) showed higher fat content
than controls and patients on HD (27.0 2.9%, 21.1 4.5%). Protein
and calorie intake were 78.6 1.80% and 62.4 18.8% of RDA
(recommended dietary allowance) in patients on HD and 74.6 18.2%
and 59.1 16.9% in patients on CAPD. Dietary vitamin intakes were
low in general, but serum vitamin levels were not lower due to
supplements. Most of the serum essential amino acid levels (leucine,
threonine, valine, tryptophan, glutamine, serine, tyrosine) were signif-
icantly decreased in both HD and CAPD patients. Our results suggest
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that many patients on maintenance dialysis show signs of protein
calorie malnutrition, although CAPD female patients tend to have
increased body fat content.
An outbreak of hemolysis in hemodialyzed uremic patients. H.J. Pyo,
K.S. Wee, S. Y. Kwon, S.G. Kim, J.S. Lee, S.H. Cho, and C.H. Cha.
Departments of Internal Medicine and Preventive Medicine, College of
Medicine, Korea University; Departments of internal Medicine and
Preventive Medicine, College of Medicine, Seoul National University,
Seoul, Korea. During the four months from December 1988 to March
1989, there was an outbreak of Heinz-body positive hemolytic anemia
in 41 patients undergoing hemodialysis in a 500 bed hospital in Seoul,
Korea. The episodes of anemia were not reduced by changing the
charcoal column and reversing the osmosis system, or by adding
ascorbic acid to the dialysate. The concentrations of nitrate, copper,
aluminum and zinc in the water were all within the standards for
hemodialysis. The chloramine concentration of the treated water was
over 0.6 mg/liter, markedly exceeding the safe level of 0.1 mg/liter. This
high level of chloramine was proved to be due to the contamination of
the water source by sewage. After changing the source of the water
supply, no further episodes of hemolytic anemia occurred. We conclude
that chloramine is one of the major contaminants causing dialysis-
induced hemolytic anemia and regular determinations are necessary,
especially during winter and dry seasons.
Effect of human recombinant erythropoietin (rHUEPO) in chronic
dialysis patients. J.D. Oh, S.O. Hwang, S.W. Kang, Y.K. Kim, K.H.
Choi, and D.S. Han, Department of Internal Medicine, Yonsei Univer-
sity College of Medicine, Seoul, Korea. Eprex, human recombinant
erythropoietin (rHuEPO) was used for treatment of anemia in patients
with end-stage renal disease (ESRD) undergoing hemodialysis (HD, N
= 6) or continuous ambulatory peritoneal dialysis (CAPD, N = 1).
Eprex® was given intravenously three times weekly after dialysis in HD
patients and twice weekly in CAPD patients in doses within the range of
50—150 lU/kg. The hematocrit started to increase within 2 weeks, and
that measured at the fourth week of treatment became significantly
higher than the pre-treatment value (mean SD, 24.7 3.3% vs. 17.9
2.1%, P < 0.05). After 4 weeks of therapy, the serum iron concen-
tration was markedly decreased from 107 97.0 rg/dl (mean SD)
before treatment to 63.2 48.0 jg/dl (P < 0.05), whereas there was no
significant change in unsaturated iron binding capacity (mean SD,
123.8 122.0 jig/dl vs. 152.2 158.0 sg/dl, P > 0.05). None of the
three previously transfusion-dependent patients needed further trans-
fusions. Along with the rise in hematocrit, 6 patients had an increase in
blood pressure. No other major side effects were noted during the
treatment. Our results suggest that human recombinant erythropoietin
can be used effectively and safely in treating anemia in these patients,
but long-term observations of its efficacy and the consequences of
increased hematocrit are needed.
Renal function changes by cyclosporin A. 1K. Jung, SR. Lee, Y.K.
Kim, and Y.S. Park, Department of Internal Medicine, Kosin Medical
College, Pusan, Korea. Changes in renal function were studied in rats
(Sprague-Dawley) treated with cyclosporine A (CsA). Animals were
subcutaneously injected with CsA (Sandimmun, Sandoz, Basel, Swit-
zerland) at a dose of 25 mg/kg/day for 4 weeks. Renal functions were
tested at 1 week intervals. CsA treatment for 4 weeks resulted in a
significant elevation of the plasma creatinine, urea and K concentra-
tions, and osmolality was decreased after 3 weeks of CsA treatment,
and then remained unchanged during the rest of the treatment period.
The creatinine clearance determined at the end of the 4 week treatment
with CsA appeared to be 60% lower than the control level. The urinary
excretions of Na, K, urea and the total osmotic substances decreased
significantly after 1 week of CsA treatment, but they returned to the
control level thereafter. The fractional excretions of water, Na, K,
urea and the total osmotic substances determined at the end of the 4
week CsA treatment were significantly higher than the control levels.
The free water reabsorption and renal medullary Na and urea contents
appeared to be significantly reduced by 3—4 weeks of CsA treatment.
Injection of Pitressin to CsA treated rats did not restore urine concen-
tration ability. These results indicate that CsA treatment in rats
attenuates the glomerular filtration rate and impairs the Na pump
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system in the ascending Henle's loop, and the latter effect leads to a
urinary concentrating defect and polyuria.
Experience in 361 renal transplants at Catholic Medical Center. Y.S.
Yoon, BK. Bang, Y.B. Koh, I.C. Kim, Y.K. Lee, T.G. Whang, Y.H.
Park, KS. Shin, and S.N. Kim, Departments of Internal Medicine, and
General Surgery, Urology, Radiology and Anesthesia, Catholic Medi-
cal Center, Seoul, Korea. Between March 1969 and April 1989, 361
renal allograft recipients were treated with either Aza + pred (N = 147)
or CsA + pred (N = 214). The actuarial patient survival rate at two
years was 82.7% for all patient groups. The corresponding graft survival
rate at two years was 78.8%. The actuarial patient survival rate at two
years was 70.8% in the Aza group and 93.8% in the CsA group (P <
0.0001), and the corresponding graft survival rate was 66.3% and 90.4%,
respectively (P < 0.0001). The actuarial graft survival rates at two years
in patients according to LRD (N = 223), NRD (N = 115) and CAD (N
= 13) were 81.8%, 73.0%, and 61.5%, respectively, which were not
significant between each group. The actuarial graft survival rates in all
LRD according to Aza- (N = 113) and CsA- (N = 120) treated groups
at two years were 72.3% and 90.1%, respectively, (P < 0.001). The
actuarial graft survival rates in all NRD according to Aza- (N = 27) and
CsA- (N = 88) treated groups at two years were 40.7% and 95.6%,
respectively (P < 0.0001). The actuarial graft survival rates in all
Aza-treated groups according to LRD (N = 113) and NRD (N = 27)
were 72.3% and 40.7%, respectively (P < 0.01). The actuarial graft
survival rates in all CsA-treated groups according to LRD (N = 120)
and NRD (N = 88) were 90.1% and 95.6%, respectively, which were not
significant.
Clinical experience in 110 renal transplants at Kyung Bee University
Medical Center (KHUMC). M.J. Kim, Y.H. Kim, T.W. Lee, C.G. Ihm,
S.G. Chang, S.E. Chai, S.H. Hong, and H.J. Joo, Departments of
Internal Medicine, Urology, and General Surgery, Kyung Hee Univer-
sity Medical Center, Seoul, Korea. Between Aug. 1978, and Dec. 1988,
110 renal transplants were performed at KHUMC. On Dec. 311988,
86% of the recipients were alive and 72% had a functioning graft. The
mean ages of recipients and donors were 35.5 and 44.4 years. Among
110 patients, 94 patients received a kidney from living related donors
(LRD), 15 from living non-related donors (LNRD), and 1 from a
cadaver donor. The most common underlying diseases were chronic
GN (87%), hypertension (9%), chronic pyelonephritis (4.6%), and so on
in order of frequency. The results of the transplantation were analyzed
according to various factors known to influence the outcome of trans-
plantation. Immunosuppression was done with azathioprine and PDL
(Aza group, N = 56) or cyclosporine and PDL (CsA group, N = 54). 1)
The overall patient survival rate (PDR) was 88% at 12 months, 79% at
24 months, and 71% at 36 months. The corresponding allograft survival
rate (GSR) was 79%, 71%, and 62%, respectively. 2) In the Aza group,
the GSR at 12 months, 24 months, and 36 months was 74%, 70% and
62%, and in the CsA group, 91%, 80% and 80%, respectively. 3) In
LRD, there was no difference in the GSR between the Aza and CsA
group but in LNRD, the GSR was higher in the CsA group than in the
Aza group. 4) The GSR was higher in the HLA identical group than in
haploidentical or mismatched groups. In HLA identical LRD, there was
no difference in the GSR between the two groups; however, in HLA
haploidentical LRD, the GSR was higher in the CsA group than in the
Aza group. 5) In general, there was no specific association between
donor age and GSR, but donor age above 60 years showed somewhat
poor allograft survival.
Clinical outcome of 130 renal transplants. H.K. Kim, J.K. Kim, D.C.
Pyun, YR. Yang, T.W. Jang, C.B. Lim, W.S. Joo, S.R. Lee, H. Y.
Rhew, and S.D. Lee, Departments of Internal Medicine, Urology and
General Surgery, Kosin Medical College, Pusan, Korea. From Dec.
1984 to Mar. 1989, 130 cases of living renal transplantations were
performed by the transplantation team of Kosin Medical College, of
which 22 cases were HLA-identical (HLA-ID), 92 cases were HLA-
haploidentical (HLA-HID), 2 cases were HLA-nonidentical (HLA-
NID) and 14 cases were living unrelated (LUR). In the HLA-HID
group, 20 cases were treated with azathioprine + steroid (Aza + P), and
64 cases were treated with cyclosporin A + steroid (CsA + P). All cases
of the HLA-ID group were treated with azathioprine + steroid. The
mean age of 130 recipients was 34.4 years, the duration of dialysis was
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12.8 months and the amount of transfusion was 11.0 pints. Seventy-two
cases of the HLA-HID group and all cases of the LUR group received
DST, but 12 cases of the HLA-HID group did not receive DST. Acute
rejection after transplantation developed in 4 of 20 cases (20.0%) of the
HLA-ID group, and in 24 of 84 cases (28.6%) of the HLA-HID group.
The actuarial graft survival rate in 3 years was 100% in the HLA-ID
group, 82.8% in the HLA-HID group and 75.2% in the LUR group. In
the HLA-HID group, the actuarial graft survival rate in 3 years was
88.4% in the CsA + P treated group and 82.5% in the Aza + P treated
group. Transfusion amounts and minor ABO incompatibility did not
show significant change in graft outcome. In the LUR group, 7 cases
who received a graft with HLA-A,B 3 antigens mismatched had a 55.6%
graft survival rate at 3 years, and 6 cases with 4 antigens mismatched
had a 100.0% graft survival rate. But 7 cases who received a graft with
HLA-DR 1 antigen mismatched had a 100.0% graft survival rate at 3
years, and 6 cases with 2 antigens mismatched had a 72.8% graft
survival rate. There were 19 graft losses in total and the most common
cause of graft loss was chronic rejection (31.6%).
A clinical study on renal transplantation in pediatric age. D.K. fin,
C. Y. Lee, H.I. Cheong, Y. Choi, and K. W. Ko, Department of
Pediatrics, Seoul National University, Seoul, Korea. A retrospective
review on the outcome of 12 children with renal transplantation (age
range: 8—15 years) in Seoul National University Hospital was carried
out with the aim of an interim evaluation for 10 years. The causes of
chronic renal failure were Henoch-SchOnlein nephritis in 3 cases, reflux
nephropathy in 2 cases, focal glomerulosclerosis in 2 cases, IgA
nephropathy in I case, and chronic sclerosing glomerulonephritis of
unknown origin in 4 cases. The kidney donors were parents in 8 cases,
sibling in 1 case, living unrelated donor in 2 cases and cadaver donor in
1 case. The period between the onset of hemodialysis and renal
transplantation ranged from 10 days to 1 year 3 months (mean 7.5
months). After renal transplantation, prednisolone and azathioprine
were given in 3 cases, and cyclosporine in 9 cases. Acute rejection was
noted in 5 patients, and 4 patients recovered from it with pulse steroid,
radiation or antilymphocytic globulin. Acute tubular necrosis accom-
panied by urinary tract infection was diagnosed in 1 case; he recovered
quickly. Cyclosporine toxicity was noted in 3 cases, however, all
recovered after withdrawal of the drug. Chronic rejection was noted in
1 case among the prednisolone and azathioprine group and in 3 cases
among the cyclosporine group. Among 4 cases with chronic rejection, 1
patient died of congestive heart failure, and 3 cases did not recover and
took maintenance hemodialysis again. In conclusion, the 4-year patient
survival rate was 0.91% and the 4-year kidney survival rate was 0.59%.
Influence of immunosuppression on the natural killer cell activity of
renal transplant recipients. K. Park, Y.S. Kim, and S.!. Kim, Depart-
ment of Surgery, Yonsei University College of Medicine, Seoul, Korea.
In 33 kidney transplant recipients, the effect of long-term maintenance
immunosuppressive therapy with either AZA/PDS or CsAIPDS on
natural killer cell activity was studied. These patients had undergone
renal transplantation at least 1 year prior to study and had a stable renal
function (serum creatinine below 2.0 mg%). A healthy control group (N
= 85) consisted of medical students and house staff, and ESRD patients
(N = 49) with maintenance HD were also studied. Four-hour chromium
release assay was used and the K-562 cell line was used as target cells.
The results were as follows:
Group No. NK activity %
Healthy control 85 33.6 16.4
ESRD 49 27.9 15.0
CsA-RTX 18 33.9 16.3
CZA-RTX 15 10.4 8.0
Conclusion: in the AZA treated group, NK activity was markedly
depressed, but in the CsA treated group NK activity was compatible
with that of healthy or ESRD patients.
Reasons necessitating the change of immunosuppressive regimen after
renal transplantation. K. Park, Y.S. Kim, S.!. Kim, and S.H. Lee,
Department of Surgery, Yonsei University College of Medicine, Seoul,
Korea. Before Feb. 1984, we used azathioprine (AZA) and steroid as an
immunosuppressive regimen in renal allografts (107 cases), but after the
introduction of cyclosporine (CsA) in Korea, we used CsA and low
dose steroid and carried out 153 transplant cases up to July 1988. During
follow-up after transplantation, we had to change the immunosuppres-
sive regimen due to various reasons. We now report the reasons for the
change and the graft outcome after the change. In the AZA-treated
group, AZA was changed to cyclophosphamide in 7 cases due to liver
dysfunction. In the CsA-treated group, the immunosuppressive regimen
was changed in 56 cases for reasons of rejection (27), CsA nephrotox-
icity (10), liver dysfunction (9), and economic reasons (8). In cases of
rejection and CsA nephrotoxicity, the regimen was converted to the
triple regimen (CsA-AZA-steroid) and followed for a minimum of 6
months. In only 3 cases, the graft function was deteriorated. In cases of
liver dysfunction (16), AZA was changed to cyclophosphamide (7) or
CsA to triple therapy (9). Four of the seven (AZA to cyclophospha-
mide) and three of the nine (CsA to triple) died due to progressive liver
failure. Four of the seven who died were HBs Ag positive. Conclusion:
1) Triple immunosuppression is a safe and reliable alternative in cases
of liver dysfunction, rejection, and CsA nephrotoxicity during follow-
up; 2) HBs Ag positivity was considered to be a poor prognostic factor
in renal transplantation.
Influence of HLA matching on outcome of 297 renal transplant
recipients. Y.S. Yoon, BK. Bang, Y.B. Koh, IC. Kim, and Y.K. Lee,
Division of Nephrology, Departments of Internal Medicine and General
Surgery, Catholic University Medical College, Seoul, Korea. The
Catholic Medical Center Transplant group followed 297 patients with
living renal transplants treated with either azathioprine (Aza; N= 87)or
cyclosporine (CsA; N = 210) for 3 months to 10 years to determine the
effect on graft survival of matching donor and recipient for HLA-A, -B,
and -DR antigens. Long-term (4 years) graft survival in the recipients
treated with Aza (P < 0.0001) or CsA (P < 0.0001) was greatly
improved by matching HLA-A and HLA-B antigens well compared to
those poorly matched. In addition, excellent results have been obtained
with HLA-A, HLA-B or HLA-DR matching in the recipients treated
with either Aza or CsA. Thus, transplants matched for HLA-DR plus
HLA-A or HLA-DR plus HLA-B had excellent results in the recipients
treated with either Aza or CsA. Especially long-term graft survival in
recipients treated with CsA was better than in those treated with Aza by
matching for HLA-A, HLA-B and HLA-DR, respectively. We con-
clude that appropriate matching for either HLA-A, HLA-B or HLA-DR
antigens is beneficial, but that matching for all antigens produces the
highest graft survival rates.
Effects of pre-existing hepatitis B virus infection on renal allograft
recipient mortality and morbidity. S.D. Hwang, H.B. Lee, MS. Park,
KS. Kim, D.K. Cho, M.J. Kim, C.G. Ihm, T.W. Lee, S.R. Lee, BK.
Bang, Y.S. Kim, CS. Park, H. Y. Oh, H.C. Oh, H.C. Park, C.M. Kang,
and C.K. Shim, Korea. We investigated the effects of pre-existing
hepatitis B virus infection on the morbidity and mortality of renal
allograft recipients. Seven centers reported data on 655 recipients.
HBsAg was detected in 59 recipients (9.0%) prior to renal transplanta-
tion. Of these 59 HBsAg (+) recipients, 15 (25.4%) had elevated
aminotransferase levels following renal transplantation and 6 (10.2%)
died of liver failure. Of 596 HB5Ag (—) recipients, 47 (7.9%) had
elevated serum aminotransferase levels but none died of liver failure.
The overall mortality was 11.9% in HBsAg (+) recipients and 8.7% in
HBsAg (—) recipients. In conclusion, renal transplantation in HBsAg
(+) subjects is associated with a significantly increased risk of hepatitis
and death from liver failure.
Immunological alterations induced by donor specific transfusion (DST)
in 134) renal transplants. H.K. Kim, J.K. Kim, D.C. Pyun, Y.R. Yang,
T,W. fang, C.B. Lim, W.W. Joo, S.R. Lee, andB.C. Park, Department
of Internal Medicine, Kosin Medical College, Pusan, Korea. The
beneficial effect of DST is now generally accepted but a considerable
incidence of presensitization after DST has been the major problem.
The mechanism by which DST induces allograft protection, however, is
still not understood. This study was designed to investigate the sensi-
tization rate after DST with immunosuppressant, and the immunologi-
cal alterations induced by DST in 130 renal transplants from Dec. 1984
to Mar. 1989. The sensitization rate after DST was 20% in the DST
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alone group, 3.6% mt he DST + Azathioprine group and 2.8% in the
DST + CyclosporinA (CsA) group. MLC tests were performed in 24 of
the HLA-HID group. And the value of the stimulation index (S.!.) after
DST (2.8 1.5) showed a slightly decreased response compared to that
before DST (2.6 2.0). Especially in the 16 cases of the DST + CsA
group, the value of S.I. after DST (2.7 1.2) was significantly
decreased compared to that before DST (4.0 2.1). No significant
changes in T cell subsets, spontaneous lymphocyte transformation and
PHA stimulation were found before and after DST. The number of cells
bearing HLA-DR (+) antigens and Con-A induced suppressor cell
activity showed slightly increased response after DST in 6 cases with
decreased MLC response (S.I.), but not to a significant degree. These
results indicate that DST with immunosuppressant reduced the presen-
sitization rate, and considering the increased Con-A induced suppressor
cell activity, increased HLA-DR (+) cells and decreased S.!. after DST,
DST may induce nonspecific immunosuppression.
Factors influencing renal allograft survival. Y.G. Kim, J.S. Han, S.
Kim, J.S. Lee, S.J. Kim, and S.T. Kim, Departments of Internal
Medicine and General Surgery, Seoul National University Hospital,
Seoul, Korea. To determine the factors influencing renal allograft
survival, we analyzed the survival of 191 grafts performed on 189
patients between 1979 and 1988 by the actuarial life table method based
on the items of the UCLA transplantation registry form. One hundred
seventy-four received living related, 14 living unrelated, and 3 cadav-
eric kidneys. Graft loss was defined as the patient's death, return to
maintenance dialysis, or removal of the graft. One and five year
survivals were 81.9% and 57.6%, and the median survival was 89
months. Factors for better graft survival (P < 0.05) were matching for
HLA-B antigen, family donors, younger age of recipients, immunosup-
pression with cyclosporine (CsA) and absence of HBs antigenemia
before operations. The most noticeable factor was HBs antigenemia.
Survival in the HBsAg (+) group (N = 22) was significantly diminished(P < 0.01) compared with the HBsAg (—) group and the difference was
prominent in patients treated with CsA but not significant in those with
azathioprine (AZA), so the one year graft survival in the HBsAg (—)
group with CsA was 92.2%. Among the 66 graft losses, 17 occurred in
the HB5Ag (+) group, and there were 4 deaths from hepatic failure
which occurred only in the HB5Ag (+) group and with CsA therapy. We
conclude that pre-existing HBs antigenemia must be considered as a
high risk factor for renal transplantation, especially in those treated
with CsA.
Interleukin-2 receptor (IL-2R) expression by peripheral blood mono-
nuclear cells (PBMC) in renal allograft recipients. H.B. Lee, C.S. Park,
M.S. Park, C. Moon, 5K. Lee, and S.D. Hwang, Hyonam Kidney
Laboratory, Seoul, Korea. The synthesis and surface expression of
IL-2R are the first events of T-lymphocyte activation. We examined
IL-2R expression of PBMC by indirect immunofluorescence staining
with anti-Tac monoclonal antibody from 25 stable renal allograft
recipients (Tx), 28 dialysis patients (Dx) and 24 healthy controls (C) to
evaluate the state of immunosuppression. The Tx patients were immu-
nosuppressed with prednisolone and azathioprine (AZA, N = 11),
prednisolone and cyclosporin A (CsA, N = 6) and prednisolone,
azathioprine and cyclosporin A (AZA + CsA, N = 8). The Dx patients
were either on hemodialysis (HD, N = 14) or continuous ambulatory
peritoneal dialysis (CAPD, N = 14). The percentage of T3 and T8 cells
was lower in Dx than in C. T3 was low in CAPD and T8 in both HD and
CAPD. The percentage of T4 cells was lower in Tx than in C, and this
was due to low T4 in the AZA + CyA group. The percentage of B cells
was lower in all Tx patients. IL-2R (+) cells were not different among
C, CAPD and all 3 Tx groups, but were lower in HD patients than in C.
In conclusion, IL-2R expression was "normal" in stable renal allograft
recipients, indicating that immunosuppression was adequate.
Immunopathologic analysis of renal allograft rejection. Y.H. Ko, M.H.
Park, f.M. Kang, and H.C. Park, Departments of Pathology and
Internal Medicine, Hanyang University College of Medicine, Seoul,
Korea. The immunopathologic changes in rejection of renal allograft
were examined on 7 open biopsies and I nephrectomy specimen. The
antibodies used were Tll, T4, T8, OKM1, Ia, Bl, IgG, 1gM, IgA, Cl,
C3, C4, and fibrinogen. Immunostaining was performed by the ABC
method and direct immunofluorescence method. The results are as
follow: 1) During rejection, the composition of the interstitial infiltrate
was heterogenous. T cells were the most frequent subpopulations with
small numbers of monocytes and plasma cells. B lymphocytes were
absent. T cell infiltrate showed a preponderance or equal numbers of T
helper/inducer cells compared to cytotoxic/suppressor cells. But in a
case of irreversible acute rejection, suppressor T cells predominated. 2)
In the glomerulus, Ia Ag was expressed on the endothelial cells and
mesangium but not on the epithelial cells. In grafts with rejection,
endothelial expression of Ia Ags tended to be decreased, except in a
case of hyperacute rejection in which Ia Ag expression appeared
markedly increased. 3) The control kidney showed no expression of Ia
Ag on tubular epithelial cells. However, grafts with rejection showed
tubular expression of Ia Ag of variable degrees which seemed to be
relatively well correlated with the degree of tubulitis. In hyperacute
rejection, there was no tubular Ia expression. 4) In blood vessels, IF
staining for 1gM, Cl and C3 was frequently seen even in cases in which
histologic evidence of vascular rejection was not obvious. In grafts with
rejection, Ia expression on the blood vessels was preserved in variable
intensity.
Autoimmune hemolytic anemia in renal transplant recipients. Y.S.
Yoon, Y.C. Oh, andB.K. Bang, Division of Nephrology, Department of
Internal Medicine, Catholic University Medical College, Red Cross
National Blood Center, Seoul, Korea. Eight patients (4.8%) among 168
renal transplant recipients treated with cyclosporine in combination
with prednisone developed autoimmune hemolytic anemia within 2
weeks of renal transplantation. All recipients (7 blood group A and I B)
had received kidneys from living donors (5 LRD and 3 NRD) who were
blood group 0 except one, group A. Blood bank serological tests
showed a positive direct and/or indirect Coombs' test in all recipients.
Anti-A, anti-B and anti-S autoantibodies were eluted from serum of
group A and B patients, respectively. In conclusion, we report here
eight patients who developed hemolytic anemia due to "autoantibod-
ies" following renal transplantation with group 0 kidneys except one, a
group A kidney. In renal transplant recipients with blood group A or B
transplanted with kidneys from group 0 donors, "autoantibody" for-
mation and hemolysis is a potential risk when cyclosporine and pred-
nisone are used for immunosuppression.
Urinary calculi in renal transplant recipients. Y.S. Yoon, S.N. Yoon,
B.K. Bang, J.H. Lee, T.G. Whang, and Y.H. Park, Division of
Nephrology, Departments of Internal Medicine and Urology, Catholic
University Medical College, Seoul, Korea. Between March 1969 and
April 1989, during a 20 year period, a total of 361 cases of kidney
transplantation were performed and we experienced 8 cases (2.2%) of
urinary calculi. Calculi were diagnosed as early as 5 months and as late
as 88 months after transplantation. The median time of diagnosis was 47
months. The location of calculi was the bladder in 7 cases, and the
grafted kidney and ureter in 1 case. The cause of calculi formation was
urinary tract infection in 5 cases, nonabsorbable suture material in 4
cases, vesicoureteral reflux in 1 case, and indeterminate in 2 cases. In
3 cases, nonabsorbable suture material and infection, both were the
cause of calculi formation. Recurrent stone formation developed in 2
cases, one of which underwent retransplantation and stone formation
occurred after retransplantation. In the other case, the second stone
was due to remnant suture material. The therapeutic application for
removal of the stone was litholapaxy in 7 cases, cystolithotomy in 2
cases, and ureterolithotomy and pyelolithotomy in 1 case. The chemical
compositions of the stones were analyzed. All grafted kidneys are well
functioning until present. In conclusions: (1) urinary calculi after renal
transplantation are relatively uncommon; (2) the most common litho-
genic factor was urinary tract infection and nonabsorbable suture
material; (3) the most common location of calculi was the bladder; and
(4) with surgical intervention, post-transplant urolithiasis does not
appear to affect graft survival.
Pregnancy in renal allograft recipients. H.B. Lee, S.D. Hwang, MS.
Park, S.K. Lee, K.S. Kim, D.K. Cho, M.J. Kim, C.G. Ihm, T.W. Lee,
H.C. Kim, S.B. Park, SR. Lee, B.H. Yu, B.K. Bang, Y.S. Kim, J.S.
Park, H.Y. Oh, H.C. Park, C.M. Kang, and J.G. Shim, Korea. We
investigated the frequency and outcome of pregnancies among renal
allograft recipients in Korea. Nine centers reported data in 918 recipi-
ents. A total of 23 pregnancies by 20 recipients (8 female and 12 male)
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or by 2.2% of all recipients were reported. Three of the 7 pregnancies
reported by female recipients ended with artificial abortion C 'therapeu-
tic" in 2) and one of the 4 successful pregnancies was complicated by
preeclampsia. One pregnancy was still in progress at the time of this
report. Only one of the 11 pregnancies reported by male recipients
ended with "therapeutic" abortion and one of the 10 successful
pregnancies gave birth to a child with congenital heart disease. Four
pregnancies were still in progress. The mean ages at transplantation and
at pregnancy were 26.9 and 30.0 years, respectively, with the mean
interval of 41.4 months. The mean serum creatinine was 1.4 mg and
BUN was 18.5 mg per 100 ml at the time of pregnancy. Immunosup-
pressive regimens at the time of pregnancy included prednisolone 14.0
mg (N = 21), azathioprine 105.6 mg (N = 18) and cyclosporin A 252.5
mg (N = 4). In conclusion, most pregnancies (67%) among renal
allograft recipients were successful without complications. It could not
be determined whether the frequent "therapeutic" abortions (22%)
among recipients were warranted.
Malignant neoplasm in renal transplant recipients. J.H. Earm, K.C.
Park, Y.J. Bang, J.S. Han, S. Kim, J.S. Lee, N.K. Kim, and Y.I. Kim,
Departments of Internal Medicine and Pathology, Seoul National
University Hospital, Seoul, Korea. To examine the relationship be-
tween immunosuppressive treatment after renal transplantation and
malignant neoplasm, we retrospectively reviewed clinical records of
218 renal transplant recipients at Seoul National University Hospital
from July 1969 to December 1988. There were six patients with
malignant neoplasm (2.8%), which were stomach cancer, basal cell
carcinoma of the skin, malignant melanoma, and hepatocellular carci-
noma, respectively, in each of four patients and Kaposi's sarcomas in
two patients. They developed 3 to 80 months after transplantation
(median 26 months). The male to female ratio was 5: 1, and the age was
from 26 to 55 years (median 46 years). The graft function at the
diagnosis of malignant neoplasm was normal except in one case of
chronic rejection in hepatocellular carcinoma. The current immunosup-
pressants were azathioprine (AZA) and prednisolone (PD) in stomach
cancer and malignant melanoma, cyclosporine A (CsA) and PD changed
to AZA and PD in the two Kaposi's sarcomas, CsA and PD in basal cell
carcinoma, and cyclophosphamide (CTX) and PD in hepatocellular
carcinoma. After diagnosis, CsA was continued in basal cell carcinoma,
but CTX and AZA were discontinued in all patients. The treatment
regimens for malignancy were surgery and chemotherapy in stomach
cancer, surgery and radiotherapy in basal cell carcinoma, surgery only
in malignant melanoma, chemotherapy only in one of the Kaposi's
sarcomas and none except discontinuance of immunosuppressant in
hepatocellular carcinoma and the other Kaposi's sarcoma. Two patients
with Kaposi's sarcomas and one with basal cell carcinoma are in
remission but the other three patients died because of malignancy.
Pulmonary tuberculosis after renal transplant. K. Park, Y.S. Kim, SI.
Kim, K.S. Shim, J. Chang, S.K. Kim, and W. Y. Lee, Departments of
Surgery and Internal Medicine, Yonsei University College of Medicine,
Seoul, Korea. Between 1979 and August 1988, 16 cases of pulmonary
tuberculosis occurred in 260 consecutive renal transplant recipients and
were reviewed at Severance Hospital, Yonsei University Medical
College. One of the patients had a previous history of tuberculosis. Five
cases died: one of hepatic failure and 4 of pulmonary infection com-
bined with rejection. Three of these cases had shown improvement for
pulmonary tuberculosis, and the other one had been treated for only
one month. One case died at the time of diagnosis without treatment.
Two cases are on treatment now and nine cases have recovered. The
results of the study are as follows: 1) The incidence of pulmonary
tuberculosis was 6.2% in this study. 2) The most common presenting
symptom was fever (80%) and twelve patients showed typical upper
lung infiltration on chest X-ray. 3) Pulmonary tuberculosis was recog-
nized within 2 years after transplantation in 12 patients; therefore, close
follow-up is very important during the early months after transplanta-
tion. Diagnostic methods such as pleural biopsy or bronchoscopic
bronchial washing are advantageous. 4) Adverse effects of RMP on
renal transplant function might be overcome by increasing the dose of
prednisone of CsA and using PZA or others instead of RMP. 5)
Antituberculous treatment regimens for renal transplant patients do not
differ from those for general tuberculous patients and the results of
chemotherapy are good.
Clinical significance of MLC (mixed lymphocyte culture) in living-
donor renal transplantation. K. Park, Y.S. Kim, SI. Kim, and C.K. Oh,
Department of Surgery, Yonsei University College of Medicine, Seoul,
Korea. We analyzed the correlation between the result of MLC and
graft survival and rejection in 236 cases of living donor renal transplan-
tation from January 1982 to January 1989, We used SI (stimulation
index) and RR (relative response) as the parameters of MLC. The
results were as follows: One hundred seventy-six cases (74.6%) had a SI
under 5 (Group I), and 60 cases (25.4%) had aS! over 5 (Group 2). A RR
under 50% (Group A) was observed in 115 cases (48.7%), and a RR over
50% (Group B) in 121 cases (51.3%). The 5-year graft survival rate was
52.8% in all 235 cases; it was 64.2% in group 1 and 50.5% in group 2.
There was no significant statistical difference between the two SI
groups (P> 0.05). However, the 5-year graft survival rate was 36.1% in
group A and 83.9% in group B, so there was a statistical difference
between these two RR groups (P < 0.05). There was acute rejection in
15 cases (9.2%) among the 163 cases of group 1, and in 5 cases (8.5%)
among the 56 cases of group 2, but this was not statistically significant
(P > 0.05). In the RR groups, there were 7 cases of acute rejection
(6.6%) in 106 cases of group A, and 13 cases (11.5%) in 113 cases of
group B. There was no significant statistical difference between the two
RR groups (P> 0.05). Conclusion: It is suggested that the results of
MLC are not correlated to the prognosis of grafts in the living-donor
renal transplants.
Beneficial effect of OKT3 in steroid-resistant renal allograft rejection.
B.S. Lee, J.H. Choi, J.H. Oh, Y.S. Yoon, andB.K. Bang, Department
of Internal Medicine, Catholic University Medical College, Seoul,
Korea. Treatment of rejection episodes using OKT3 has already been
reported to be more effective than conventional immunosuppressive
treatment. Despite unresolved limitations for use, OKT3 monoclonal
antibody has already allowed clinical immunosuppression and is a
successful prototype for future protocols that may seek even more
selective manipulation of the immune response. Three patients experi-
enced acute graft rejection, and no clinical improvement followed pulse
methylprednisolone (0.5 g i.v. for 3 days). Renal biopsy was performed
in one patient 3 days following pulse steroids, and showed severe
cellular rejection. The incidences of side effects following OKT3
therapy were chills and fever (3/3), nausea and vomiting (2/3), dyspnea
and wheezing (2/3), conjunctival injection (2/3), etc. All three patients
maintained normal renal function.
Donor-specific transfusion in cyclosporine-treated renal transplants.
Y.S. Yoon, I.S. Park, S. Y. Kim, W.S. Koo, E.J. Choi, and B.K. Bang,
Department of Internal Medicine, Catholic University Medical College,
Seoul, Korea. At the Catholic Medical Center Transplant Group, a
donor-specific transfusion (DST) program was initiated in 1984 to see if
the graft survival in recipients with one-haplotype matched living-
related donor (LRD), non-living related donor (NRD), and high-mixed-
lymphocyte culture donor-recipient pairs could be improved further by
using stored blood with azathioprine. The incidence of recipient sensi-
tization was as low as 2.7%. The actuarial patient survival rate at two
years was 96.7% in the DST group (N = 74) and 91.9% in the non-DST
group (N = 137), which was not significant. The corresponding graft
survival rate at two years was 92.1% and 91%, respectively, which was
not statistically significant. The actuarial graft survival rate for the DST
group at two years was 89.2% in LRD (N = 37), and 97.0% in NRD (N
= 37), which was not significant. Our experience suggests that DST
offers no advantage for the graft survival rate in CsA-treated recipients,
since it is time consuming, expensive and has a potential risk of
recipient sensitization.
Pathologic analysis of renal allograft. Y.H. Ko and M.H. Park,
Department of Pathology, College of Medicine, Hanyang University
College of Medicine, Seoul, Korea. We analyzed the pathologic find-
ings of kidney allografts. Twenty-eight renal biopsies and 5 nephrec-
tomy specimens were obtained from a total of 27 renal allograft patients
who showed renal dysfunction after renal transplantation. 1) Among 33
cases, 24 cases showing moderate to severe rejection were classified as
hyperacute rejection in 2 cases and acute rejection in 13 cases, including
predominantly acute cellular rejection in 10 cases, acute cellular and
humoral rejection in I case and acute humoral rejection in 2 cases.
There were 9 chronic humoral rejection cases, among which 3 cases
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were associated with acute cellular rejection and 4 other cases were
associated with acute humoral rejection. 2) Except in 2 cases of
hyperacute rejection, the mean duration from transplantation to biopsy
or nephrectomy was 20.5 months (range 15 days—82 months) in all cases
irrespective of histologic type, 21.3 months in acute rejection (22.3
months in acute cellular rejection and 20.5 months in acute humoral
rejection) and 31.6 months (range 6—82 months) in chronic rejection. 3)
There were 6 cases of transplant glomerulopathy, all of which were
associated with rejection of a severe degree. 4) Cyclosporine toxicity
was noted in two cases, one of whom died of severe immunodeficiency
and infection. 5) Dc novo membranous glomerulopathy was identified in
6 cases obtained from 4 patients, 5 of which were associated with
varying degrees of rejection. 6) There were 4 cases of recurrent
diseases, including IgA nephropathy in 2 patients, and Henoch-SchOn-
1cm nephropathy and diabetic glomerulosclerosis in one patient each,
respectively.
Results of conversion from cyclosporine to azathioprine in living-
related renal transplantation. Y.H. Kim, T. W. Lee, C.G. Ihm, and M.J.
Kim, Department of Internal Medicine, Kyung Hee University Medical
Center, Seoul, Korea. There is a debate about the results of rejection
episodes and allograft function after conversion from cyclosporine
(CsA) to azathioprine (Aza) in renal transplantation. The conversion
protocols varied from 1 month to 12 months after renal transplantation.
Some groups recommend conversion and some groups are against it.
Between Aug. 1978 and Dec. 1988, 110 renal transplants were per-
formed at our center and immunosuppressive regimens were converted
from CsA to Aza in 34 patients who received a kidney from living
related donors. We have analyzed our experiences about rejection
episodes (number/patient), allograft function and survival rate after
CsA-to-Aza conversion. There was no difference in the degree of HLA
matching, transfusion number, donor age and so on among the CsA
group (N = 10), group A (1 month conversion, N = 8), group B (3
month conversion, N = 9), group C (6 month conversion, N = 9) and
group D (12 month conversion, N = 8). The results were as follows: 1)
The average rejection episode was 0.15 in all conversion patients and
rejections usually occurred within 3 months after conversion. 2) Within
1 year after conversion, no rejection occurred in the CsA group B, and
0.25 episodes of rejection occurred in group A, 0.22 in group C and
0.125 in group D. 3) The one-year graft survival rate was 100% in the
CsA group, 88% in group A, 100% in group B, 100% in group C, and
88% in group D. In conclusion, conversion from cyclosporine to
azathioprine may be performed with safety in kidney recipients from
living related donors one month after transplantation.
Influence of donor age on allograft function and survival in living-
related renal transplant recipients. Y.H. Kim, T. W. Lee, C.G. Ihm, and
M.J. Kim, Department of Internal Medicine, Kyung Hee University
Medical Center, Seoul, Korea. Aging is associated with a decline in
GFR. Glomerulosclerosis and intrarenal vascular disease may be re-
sponsible for diminution in renal function associated with aging. Donor
age was known to influence the renal outcome following renal trans-
plantation. Some debated that donor age may affect allograft function or
survival. We investigated the effects of donor age on allograft function
and allograft survival in 110 renal transplants at Kyung Hee University
Medical Center. Donor age was divided by 15 years: group A (16—30
years, N = 27), group B (31—45 years, N = 24), group C (46—60 years,N = 49), and group D (60—65 years, N = 9). Immunosuppressive
regimens, degree of HLA matching and other variables were not
different among the groups. 1) The one-year graft survival rate was 93%
in group A, 80% in group B, 87% in group C, and 73% in group D. 2) The
time needed for serum creatinine to decline below 2 mg/dl following
renal transplantation did not differ among groups. 3) In recipients with
an allograft survival period longer than 12 months, graft function after
1 year of transplantation (serum creatinine level) showed no significant
difference among groups. In conclusion, the kidney from the donor
below the age of 65 years may be used with no significant difference of
risk on graft survival rates and/or graft functions.
A case of chronic renal failure associated with tuberous sclerosis. S.N.
Yoon, Y.S. Yoon, B.K. Bang, W.J. Yang, S.K. Chung, and H.O. Kim,
Departments of Internal Medicine, Radiology and Dermatology, Cath-
olic Medical College, Seoul, Korea. Tuberous sclerosis is a rare disease
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which occurs sporadically or hereditarily and is recognized by its
neurological and dermatological manifestations. The classical triad is
composed of seizure, mental retardation and adenoma sebaceum on the
face. A 33-year-old woman was hospitalized with end-stage renal
disease and a maintenance hemodialysis was initiated. EEG showed
abnormal patterns which were characterized by the slow delta and theta
ranged activities noted in the generalized distribution. No epileptiform
discharge was present. She had no history of anticonvulsive manage-
ment and experienced a seizure attack during the first hemodialysis.
Abdominal CT showed angiomyolipoma of both kidneys and multiple
cystic lesions on both adnexae and the retroperitoneal space. This was
characterized by dermal fibrosis with concentric perifollicular fibrosis
and focal capillary telangiectasia. The patient suffered from bilateral
pneumothorax that resulted from involvement of the lung with tuberous
sclerosis. An emergency thoracotomy tube was inserted. She has been
managed with hemodialysis until the present.
Clinical study on the congenital anomalies of the kidney and upper
urinary tract system. J.K. Rhim and J.S. Lee, Department of Pediat-
rics, Yonsei University, College of Medicine, Seoul, Korea. The
medical records of patients with anomalies of the urogenital system
during the 10 year period from July 1978 to June 1988 were reviewed
and analyzed for incidence, age and sex distribution, location of the
lesion and associated diseases. As a result, anomalies of the kidney and
upper urinary tract were found in 179 patients. Vesicoureteral reflux in
68 patients was most common, followed by ureteropelvic junction
stenosis, double collecting system, ureterovesical junction stenosis,
ureterocele, and ectopic ureter. The male to female sex ratio of the
patients with vesicoureteral reflux was 1.3: 1, and the other anomalies
were associated in 14 cases. Patients under 1 year of age comprised
32%. In 42 patients with ureteropelvic junction stenosis, the male to
female ratio was 2.8: 1 and male patients predominated, especially
under 1 year of age. Among 36 patients with double collecting system,
17 accompanied other anomalies, of which ureterocele was the most
frequent finding, accounting for 6 cases. The male to female ratio was
1.6, and patients under 3 years of age comprised 50%. In vesi-
coureteral reflux, ureteropelvic junction stenosis, and double collecting
system, unilateral cases outnumbered bilateral ones. Especially in both
vesicoureteral reflux and ureteropelvic junction stenosis, a great num-
ber of cases occurred on the left side. In double collecting system, the
complete type was most common, comprising 50% of the cases.
Meanwhile, anomalies localized in the kidney were detected in 32
cases, among which polycystic kidney was most common, accounting
for 9 cases, followed by 8 cases of unilateral renal agenesis, 5 of renal
dysplasia, 3 of horseshoe kidney and 2 of renal ectopia. There were 15
patients who also had anomalies in other organ systems, such as
cardiovascular, neuroectodermal, urogenital, skeletal, gastrointestinal
and chromosomal anomalies.
An analysis of 2514 cases of renal biopsy/necropsy in Korea. I.J. Choi,
H.J. Jeong, D.S. Han, J.S. Lee, H.Y. Lee, andP.K. Kim, Departments
of Pathology, Internal Medicine and Pediatrics, Yonsei University
College of Medicine, Seoul, Korea. To evaluate the distribution pattern
of renal diseases based on needle biopsy, we analyzed 2514 cases of
renal biopsy or necropsy materials examined at the Department of
Pathology from 1973 to 1988. Excluding 57 cases of biopsy failure and
96 cases of insufficient or inadequate materials, a total of 2361 cases
were studied. The average age was 21.1 years for males and 23.7 years
for females. The adults were 602% and the children 39.8%. The male to
female ratio was 1.6:1 in adults and 2.3:1 in children. Glomerular
diseases were 97.8% of the total: primary glomerulonephritis (GN)
59.8% and secondary GN 27.6%. The major glomerular diseases were
lipoid nephrosis (LN; 24.2%), IgA nephropathy (IgAN; 17.8%), benign
recurrent hematuria (BRH; 8.8%), membranous GN (MGN; 7.9%),
acute poststreptococcal GN (APSHN; 7.3%), mesangioproliferative
GN (MspGN; 5.5%), mesangiopathy (5.5%), membranoproliferative
GN (4.1%), and focal segmental glomerulosclerosis (FSGS; 2.7%) in
descending order of frequency. ON of systemic diseases included 77
cases of lupus nephritis, 157 cases of Henoch-Schönlein purpura
nephritis (HSP-N) and 7 cases of systemic infection excluding B viral
hepatitis. The most common glomerular diseases were LN, IgAN,
MGN and MspGN in adults, and BRH, HSP-N and children. HBs
antigenemia was found in 71 cases, of which MGN and IgAN were the
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most frequent. HBs antigenemia associated MGN was prevalent in
male children, whereas IgAN was prevalent in adults. A repeat biopsy
was to first biopsy failure (22 cases) or to evaluate the treatment
response. Three cases of LN were confirmed to be FSGS by the second
biopsy.
Interleukin-2 (IL-2) production in uremic and dialysis patients. K.H.
Choi, Y.K. Kim, S.K. Ha, H. Y. Lee, and D.S. Han, Department of
Internal Medicine, Yonsei University College of Medicine, Seoul,
Korea. In order to assess the alterations of cell-mediated immunity in
patients with chronic renal failure, blastogenesis and interleukin-2
(IL-2) production of peripheral blood lymphocytes following PHA
stimulation were measured in pre-dialysis uremic patients (N = 13), and
in patients undergoing chronic hemodialysis (HD, N = 19) or continu-
ous ambulatory peritoneal dialysis (CAPD, N = 13) for over 3 months.
IL-2 production reflected by short-term tritiated uptake of cytotoxic
lymphoid line 2 (CTLL 2) was highly elevated in the pre-dialysis uremic
(mean SD, 16.7 11.7 U/mI) and hemodialysis group (14. 11.0),
compared to the control (5.6 2.5) or CAPD group (8.0 5.3; P <
0.05). With respect to the mitogenic response to PHA (10 igJml),
stimulation index, expressed as the ratio of thymidine incorporation
(cpm) in stimulated culture to that in control culture, was not signifi-
cantly different in all patient groups (mean SD, pre-dialysis: 801.8
322.3, HD: 885.1 435.9, CAPD: 822.3 435.0, control group: 974.9
436.3; F> 0.05). No significant correlation between IL-2 production
and mitogenic response of lymphocyte was noted in both control and
uremic subjects. Our results suggest that in pre-dialysis uremic and HD
patients, PHA-induced IL-2 production was activated, whereas this
activation was not associated with enhanced lymphocyte blastogenesis.
Clinical manifestation of carbon disulfide intoxication. K.B. Lee, H.J.
Byoun, T.S. Choi, E.J. Lee, W. Y. Cho, and H.K. Kim, Department of
Internal Medicine, College of Medicine, Korea University, Seoul,
Korea. Carbon disulfide is a volatile liquid which is colorless and has an
aromatic odor at room temperature. It has been usually used as a
solvent for the spinning process in viscose rayon plants, and also in
cellophane and agricultural medicine plants. We have experience with
16 rayon plant workers who possibly suffer from carbon disulfide
intoxication. Accordingly, we are reporting our synthetic opinions
regarding the above cases. The patients have worked in the spinning
department in rayon plants for 6 to 18 years. Their ages range from 38
to 51 years, and 10 persons are male and 6 are female. With respect to
clinical findings, we could find the neurological symptoms of neuralgia
(93%), headache (68%), decreased sexual libido (63%), visual distur-
bance (50%), and hearing disturbance (43%), and in addition, hyperten-
sion (38%), edema (12%), etc., were observed. With respect to labora-
tory findings, 2 patients showed anemia, 2 patients azotemia, 1 patient
impaired glucose tolerance and there were no abnormal findings in LFT
and lipid study. Three patients showed hemorrhage and exudate in
funduscopy. Four patients showed sensory-neural hearing loss and 3
patients polyneuropathy on EMG examination.
Alteration of T lymphocyte subsets and interleukin-2 after achieving
remission in children with minimal change nephrotic syndrome (II). M.S.
Park, S.J. Ko, and P.K. Kim. Department of Pediatrics, Yonsei
University, College of Medicine, Seoul, Korea. The concept that T
lymphocytes and lymphokines are involved in the pathogenesis and
treatment of minimal change nephrotic syndrome (MCNS) has been
suggested previously. However, in our first report there were not
enough cases to have any statistical significance. In this report we have
added and analyzed additional cases in regard to the alteration of T cell
subsets and interleukin-2 (IL-2) before and after remission. Thirty
children with MCNS, clinically and pathologically confirmed, from
March 1987 to March 1989 were included in the study. During the
period of admission and follow-up, T cell subsets (T4, T8, T41T8 ratio)
and IL-2 were determined and compared according to the clinical type
and therapeutic agents used. T4 and T4/T8 ratio significantly decreased
after achieving remission; from 43.73% to 36.55% forT4 and from 1.70
to 1.45 for T4/T8 ratio, while T8 increased from 28.50% to 30.27%. This
was true regardless of the clinical type (MCNS fresh ease, steroid-
dependent MCNS, steroid-resistant MCNS and frequent relapsers) and
therapeutic agents used (prednisone alone, cyclophosphamide with
prednisone and cyclosporin with prednisone). Therefore, it may be said
that the remission of MCNS is related to the decrease in T4 and T4/T8
ratio, and this in turn implies the inhibitory action of the therapeutic
agents on helper I cells, which is especially related to the action
mechanism of cyclosporine.
